Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

OPY vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OPY
Oppenheimer Holdings Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$1.02B
5Y Perf.+355.1%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$307.53B
5Y Perf.+337.3%

OPY vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OPY logoOPY
MS logoMS
IndustryFinancial - Capital MarketsFinancial - Capital Markets
Market Cap$1.02B$307.53B
Revenue (TTM)$1.64B$103.14B
Net Income (TTM)$148M$16.18B
Gross Margin51.1%55.6%
Operating Margin22.4%17.1%
Forward P/E116.1x16.3x
Total Debt$628M$360.49B
Cash & Equiv.$38M$75.74B

OPY vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OPY
MS
StockMay 20May 26Return
Oppenheimer Holding… (OPY)100455.1+355.1%
Morgan Stanley (MS)100437.3+337.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: OPY vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Oppenheimer Holdings Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
OPY
Oppenheimer Holdings Inc.
The Banking Pick

OPY is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.01, Low D/E 63.0%, current ratio 5.99x
  • Beta 1.01, yield 0.7%, current ratio 5.99x
  • Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
Best for: sleep-well-at-night and defensive
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 11 yrs, beta 1.37, yield 2.0%
  • Rev growth 16.8%, EPS growth 53.5%
  • 7.4% 10Y total return vs OPY's 6.6%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMS logoMS16.8% NII/revenue growth vs OPY's 14.4%
ValueMS logoMSLower P/E (16.3x vs 116.1x), PEG 1.83 vs 16.60
Quality / MarginsOPY logoOPYEfficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
Stability / SafetyOPY logoOPYBeta 1.01 vs MS's 1.37, lower leverage
DividendsMS logoMS2.0% yield, 11-year raise streak, vs OPY's 0.7%
Momentum (1Y)MS logoMS+66.7% vs OPY's +63.4%
Efficiency (ROA)OPY logoOPYEfficiency ratio 0.3% vs MS's 0.4%

OPY vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OPYOppenheimer Holdings Inc.
FY 2025
Advisory Fees
65.7%$555M
Investment Banking, Capital Markets
18.1%$153M
Investment Banking, Advisory
13.4%$114M
Other
2.7%$23M
MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B

OPY vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLOPYLAGGINGMS

Income & Cash Flow (Last 12 Months)

OPY leads this category, winning 3 of 5 comparable metrics.

MS is the larger business by revenue, generating $103.1B annually — 63.0x OPY's $1.6B. Profitability is closely matched — net margins range from 13.0% (MS) to 9.1% (OPY).

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
RevenueTrailing 12 months$1.6B$103.1B
EBITDAEarnings before interest/tax$416M$26.3B
Net IncomeAfter-tax profit$148M$16.2B
Free Cash FlowCash after capex$184M-$6.7B
Gross MarginGross profit ÷ Revenue+51.1%+55.6%
Operating MarginEBIT ÷ Revenue+22.4%+17.1%
Net MarginNet income ÷ Revenue+9.1%+13.0%
FCF MarginFCF ÷ Revenue+11.2%-2.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+5.9%+48.9%
OPY leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

OPY leads this category, winning 5 of 6 comparable metrics.

At 7.4x trailing earnings, OPY trades at a 70% valuation discount to MS's 24.3x P/E. Adjusting for growth (PEG ratio), OPY offers better value at 1.06x vs MS's 2.73x — a lower PEG means you pay less per unit of expected earnings growth.

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
Market CapShares × price$1.0B$307.5B
Enterprise ValueMkt cap + debt − cash$1.6B$592.3B
Trailing P/EPrice ÷ TTM EPS7.39x24.31x
Forward P/EPrice ÷ next-FY EPS est.116.13x16.28x
PEG RatioP/E ÷ EPS growth rate1.06x2.73x
EV / EBITDAEnterprise value multiple5.81x26.03x
Price / SalesMarket cap ÷ Revenue0.62x2.98x
Price / BookPrice ÷ Book value/share1.10x2.95x
Price / FCFMarket cap ÷ FCF5.57x
OPY leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

OPY leads this category, winning 9 of 9 comparable metrics.

OPY delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $15 for MS. OPY carries lower financial leverage with a 0.63x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x. On the Piotroski fundamental quality scale (0–9), OPY scores 7/9 vs MS's 5/9, reflecting strong financial health.

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+16.1%+14.6%
ROA (TTM)Return on assets+4.0%+1.2%
ROICReturn on invested capital+17.4%+2.9%
ROCEReturn on capital employed+12.0%+3.8%
Piotroski ScoreFundamental quality 0–975
Debt / EquityFinancial leverage0.63x3.42x
Net DebtTotal debt minus cash$590M$284.7B
Cash & Equiv.Liquid assets$38M$75.7B
Total DebtShort + long-term debt$628M$360.5B
Interest CoverageEBIT ÷ Interest expense3.36x0.44x
OPY leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — OPY and MS each lead in 3 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $20,257 for OPY. Over the past 12 months, MS leads with a +66.7% total return vs OPY's +63.4%. The 3-year compound annual growth rate (CAGR) favors OPY at 38.3% vs MS's 34.3% — a key indicator of consistent wealth creation.

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+32.9%+7.4%
1-Year ReturnPast 12 months+63.4%+66.7%
3-Year ReturnCumulative with dividends+164.8%+142.1%
5-Year ReturnCumulative with dividends+102.6%+142.2%
10-Year ReturnCumulative with dividends+657.5%+739.4%
CAGR (3Y)Annualised 3-year return+38.3%+34.3%
Evenly matched — OPY and MS each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — OPY and MS each lead in 1 of 2 comparable metrics.

OPY is the less volatile stock with a 1.01 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs OPY's 81.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5001.01x1.37x
52-Week HighHighest price in past year$118.77$194.83
52-Week LowLowest price in past year$59.69$117.21
% of 52W HighCurrent price vs 52-week peak+81.2%+99.2%
RSI (14)Momentum oscillator 0–10044.761.2
Avg Volume (50D)Average daily shares traded66K5.4M
Evenly matched — OPY and MS each lead in 1 of 2 comparable metrics.

Analyst Outlook

MS leads this category, winning 2 of 2 comparable metrics.

Wall Street rates OPY as "Buy" and MS as "Buy". Consensus price targets imply 107.5% upside for OPY (target: $200) vs 6.5% for MS (target: $206). For income investors, MS offers the higher dividend yield at 1.97% vs OPY's 0.69%.

MetricOPY logoOPYOppenheimer Holdi…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$200.00$205.75
# AnalystsCovering analysts252
Dividend YieldAnnual dividend ÷ price+0.7%+2.0%
Dividend StreakConsecutive years of raises211
Dividend / ShareAnnual DPS$0.66$3.81
Buyback YieldShare repurchases ÷ mkt cap+0.3%+1.4%
MS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

OPY leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MS leads in 1 (Analyst Outlook). 2 tied.

Best OverallOppenheimer Holdings Inc. (OPY)Leads 3 of 6 categories
Loading custom metrics...

OPY vs MS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is OPY or MS a better buy right now?

For growth investors, Morgan Stanley (MS) is the stronger pick with 16.

8% revenue growth year-over-year, versus 14. 4% for Oppenheimer Holdings Inc. (OPY). Oppenheimer Holdings Inc. (OPY) offers the better valuation at 7. 4x trailing P/E (116. 1x forward), making it the more compelling value choice. Analysts rate Oppenheimer Holdings Inc. (OPY) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OPY or MS?

On trailing P/E, Oppenheimer Holdings Inc.

(OPY) is the cheapest at 7. 4x versus Morgan Stanley at 24. 3x. On forward P/E, Morgan Stanley is actually cheaper at 16. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Morgan Stanley wins at 1. 83x versus Oppenheimer Holdings Inc. 's 16. 60x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — OPY or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.

2%, compared to +102. 6% for Oppenheimer Holdings Inc. (OPY). Over 10 years, the gap is even starker: MS returned +739. 4% versus OPY's +657. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OPY or MS?

By beta (market sensitivity over 5 years), Oppenheimer Holdings Inc.

(OPY) is the lower-risk stock at 1. 01β versus Morgan Stanley's 1. 37β — meaning MS is approximately 36% more volatile than OPY relative to the S&P 500. On balance sheet safety, Oppenheimer Holdings Inc. (OPY) carries a lower debt/equity ratio of 63% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

05

Which is growing faster — OPY or MS?

By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.

8% versus 14. 4% for Oppenheimer Holdings Inc. (OPY). On earnings-per-share growth, the picture is similar: Oppenheimer Holdings Inc. grew EPS 104. 7% year-over-year, compared to 53. 5% for Morgan Stanley. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OPY or MS?

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus 9. 1% for Oppenheimer Holdings Inc. — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPY leads at 22. 4% versus 17. 1% for MS. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OPY or MS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Morgan Stanley (MS) is the more undervalued stock at a PEG of 1. 83x versus Oppenheimer Holdings Inc. 's 16. 60x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Morgan Stanley (MS) trades at 16. 3x forward P/E versus 116. 1x for Oppenheimer Holdings Inc. — 99. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPY: 107. 5% to $200. 00.

08

Which pays a better dividend — OPY or MS?

All stocks in this comparison pay dividends.

Morgan Stanley (MS) offers the highest yield at 2. 0%, versus 0. 7% for Oppenheimer Holdings Inc. (OPY).

09

Is OPY or MS better for a retirement portfolio?

For long-horizon retirement investors, Oppenheimer Holdings Inc.

(OPY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 0. 7% yield, +657. 5% 10Y return). Both have compounded well over 10 years (OPY: +657. 5%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OPY and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OPY is a small-cap deep-value stock; MS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

OPY

Stable Dividend Mega-Cap

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OPY and MS on the metrics below

Revenue Growth>
%
(OPY: 14.4% · MS: 16.8%)
Net Margin>
%
(OPY: 9.1% · MS: 13.0%)
P/E Ratio<
x
(OPY: 7.4x · MS: 24.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.